T-cell receptor-engineered T cells (TCR-e T cells): A novel cellular therapy for hematopoietic malignancies?
{{output}}
Despite the undeniable successes of chimeric antigen receptor T cells in the treatment of numerous hematopoietic malignancies, instances in which this therapy shows limited effectiveness, such as in acute myeloid leukemia (AML), still exists. This situation ha... ...
